Logo for MetaVia Inc

MetaVia Investor Relations Material

Latest events

Logo for MetaVia

Q4 2024

20 Mar, 2025
Logo for MetaVia

Study Result

9 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from MetaVia Inc

Access all reports
MetaVia Inc is a U.S.-based biotechnology company focused on developing treatments for metabolic and rare genetic diseases. The company is engaged in the research and clinical development of novel therapeutics targeting underlying disease mechanisms, with a goal of addressing unmet medical needs. MetaVia utilizes proprietary technology platforms and collaborates with research institutions to advance its pipeline. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.